New Key Statistics Module, Z-Score and F-Score
SZSE:300878 Key Ratios
Market Cap ¥ M | 2,571.48 |
Enterprise Value ¥ M | 2,500.60 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.89 |
Price/Sales | 4.56 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 523.00 |
EPS (TTM) ¥ | -0.08 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -19.50 |
y-y EBITDA Growth Rate % | -166.40 |
EV-to-EBIT | -924.44 |
EV-to-EBITDA | -924.44 |
PEG | -- |
Shares Outstanding M | 144.79 |
Net Margin (%) | -2.14 |
Operating Margin % | -5.07 |
Pre-tax Margin (%) | -2.30 |
Quick Ratio | 4.53 |
Current Ratio | 5.48 |
ROA % (ttm) | -0.57 |
ROE % (ttm) | -0.79 |
ROIC % (ttm) | -1.45 |
Dividend Yield % | -- |
Altman Z-Score | 5.57 |
SZSE:300878 Number of Guru Trades
SZSE:300878 Volume of Guru Trades
Gurus Latest Trades with SZSE:300878
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300878 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Wecome Pharmaceutical Co Ltd Insider Transactions
No Available Data